The U.S. Food and Drug Administration building in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times
The Food and Drug Administration has halted a program that allowed the transfer of U.S. citizens’ biological samples to China and other “hostile countries.”
The FDA’s ban and review are a necessary move to bolster U.S. biosecurity against the potential threat of biological warfare and bioterror by the Chinese Communist Party (CCP), said experts who spoke with the Chinese-language edition of The Epoch Times.
Ohio State Agrees to $2.1 Million Federal Settlement Over Undisclosed China Research Ties
Ohio State University has agreed to pay $2.1 million to resolve federal...
Chinese Scientists Flagged Glacial Flood Danger One Year Before Nepal Catastrophe
More than a year before the catastrophic flash flood devastated the China–Nepal...
Chinas Humanoid Robot Companies Face Reality Check
China is showcasing humanoid robots as symbols of its technological ambitions. However,...
USDA Unveils New Support for Ranchers to Rebuild Cattle Herds
The U.S. Department of Agriculture has unveiled a new package of measures...
